Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Today's Moved Stocks, Notable Stocks - 8/21 (Wed)

avatar
moomooニュース日本株 wrote a column · Aug 20 21:00
Today's Moved Stocks, Notable Stocks - 8/21 (Wed)
Good morning to all moomoo users! We will deliver notable stocks and the latest rating information from the front market.
Today's strong and weak ingredients
8/21 [Strong and Weak Materials]
3 points to pay attention to in the front field
Developments in terms of exchange
$Ye Digital (2354.JP)$The revised earnings forecast for the fiscal year ending 2025/2 was announced. Sales were revised upward from 20 billion yen to 20.3 billion yen, and operating profit was revised upward from 1.6 billion yen to 1.8 billion yen.
$Taisei (1801.JP)$, provides concrete crack detection technology, and measures against aging infrastructure
Stocks that have moved, notable stocks
$Nitori Holdings (9843.JP)$It continued to grow for 4 days. The appreciation of the yen has been well received.
$Mitsui Chemicals (4183.JP)$Continued growth. The company announced that it is expected to restart the ethylene plant of Osaka Petrochemical, which is a subsidiary, from October.
$Dai-ichi Life Holdings (8750.JP)$has declined drastically. The decline in long-term interest rates in Japan and the US is frowned upon.
$Tokyo Electric Power (9501.JP)$has declined. The morning edition of the Nihon Keizai Shimbun reported that Japan Nuclear Power has postponed the completion period of safety measures construction at the Tokai No. 2 Nuclear Power Plant (Tokai-mura, Ibaraki-ken).
$Mitsubishi Heavy Industries (7011.JP)$It continued to fall for 3 days. The morning edition of the Nihon Keizai Shimbun reported that the company will team up with US Chevron, a major petroleum company, to embark on a business to produce and store hydrogen from renewable energy in the United States. Note that the positive impact on stock prices has been limited.
$Daiichi Sankyo (4568.JP)$has declined. On the 20th, the American pharmaceutical company Eli Lilly announced the results of a 94% reduction in the risk of progression to type 2 diabetes in a test of the obesity treatment drug “tilzepatide,” which aims to delay progression to diabetes in obese or overweight adults. In response to this announcement, Eli Lilly's stock price rose 3% from the previous day in the US market on the same day.
Meanwhile, they sell medicines to treat diabetes $Daiichi Sankyo (4568.JP)$Ya $Sawai Group Holdings (4887.JP)$etc., it seems that sales are coming out due to concerns about future earnings.
Source: FISCO, MINKABU
-MOOMOO News Kouchi
Today's Moved Stocks, Notable Stocks - 8/21 (Wed)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
15
+0
See Original
Report
40K Views
Comment
Sign in to post a comment
    avatar
    moomoo News Official Account
    17KFollowers
    4Following
    156KVisitors
    Follow